Professor Lindy Durrant, CEO, Scancell Holdings P 00:00:00

Share On Facebook Share On Twitter

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the initial phase of the clinical stage biopharmaceutical company's Phase 2 SCOPE trial in advanced melanoma.

Recent Videos